XERIS PHARMACEUTICALS INC Operating Cash Flow
XERIS PHARMACEUTICALS INC reported Operating Cash Flow of -$43.98 million for the 6-month period ending 2021-06-30, per its 10-Q filed 2021-08-05.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2021-08-05
- XERIS PHARMACEUTICALS INC net cash provided by (used in) operating activities for the quarter ending 2021-06-30 was -$20.02M.
- XERIS PHARMACEUTICALS INC net cash provided by (used in) operating activities for the quarter ending 2021-03-31 was -$23.96M.
- XERIS PHARMACEUTICALS INC net cash provided by (used in) operating activities for the quarter ending 2020-12-31 was -$10.87M.
- XERIS PHARMACEUTICALS INC net cash provided by (used in) operating activities for the quarter ending 2020-09-30 was -$16.98M.
- XERIS PHARMACEUTICALS INC net cash provided by (used in) operating activities for fiscal 2020 was -$80.56M.
- XERIS PHARMACEUTICALS INC net cash provided by (used in) operating activities for fiscal 2019 was -$104.35M.
- XERIS PHARMACEUTICALS INC net cash provided by (used in) operating activities for fiscal 2018 was -$56.28M.
- XERIS PHARMACEUTICALS INC net cash provided by (used in) operating activities for fiscal 2017 was -$24.66M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2021-06-30 | -$20.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$43.98M 10-Q · filed 2021-08-05 | -$54.85M derived: sum of 3 quarters · filed 2021-08-05 | -$71.83M derived: sum of 4 quarters · filed 2021-08-05 |
| 2021-03-31 | -$23.96M 10-Q · filed 2021-05-13 | -$34.83M derived: sum of 2 quarters · filed 2021-05-13 | -$51.81M derived: sum of 3 quarters · filed 2021-05-13 | -$75.57M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-12-31 | -$10.87M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09 | -$27.85M derived: sum of 2 quarters · filed 2021-03-09 | -$51.61M derived: sum of 3 quarters · filed 2021-08-05 | -$80.56M 10-K · filed 2021-03-09 |
| 2020-09-30 | -$16.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$40.74M derived: sum of 2 quarters · filed 2021-08-05 | -$69.69M 10-Q · filed 2020-11-09 | -$99.26M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-06-30 | -$23.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$52.70M 10-Q · filed 2021-08-05 | -$82.28M derived: sum of 3 quarters · filed 2021-08-05 | -$112.86M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | -$28.95M 10-Q · filed 2021-05-13 | -$58.52M derived: sum of 2 quarters · filed 2021-05-13 | -$89.10M derived: sum of 3 quarters · filed 2021-05-13 | -$112.14M derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | -$29.57M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09 | -$60.16M derived: sum of 2 quarters · filed 2021-03-09 | -$83.19M derived: sum of 3 quarters · filed 2021-03-09 | -$104.35M 10-K · filed 2021-03-09 |
| 2019-09-30 | -$30.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$53.62M derived: sum of 2 quarters · filed 2020-11-09 | -$74.77M 10-Q · filed 2020-11-09 | -$93.11M derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | -$23.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$44.19M 10-Q · filed 2020-08-10 | -$62.53M derived: sum of 3 quarters · filed 2020-08-10 | -$78.44M derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-03-31 | -$21.15M 10-Q · filed 2020-05-07 | -$39.49M derived: sum of 2 quarters · filed 2020-05-07 | -$55.41M derived: sum of 3 quarters · filed 2020-05-07 | -$69.63M derived: sum of 4 quarters · filed 2020-05-07 |
| 2018-12-31 | -$18.34M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | -$34.25M derived: sum of 2 quarters · filed 2020-03-12 | -$48.47M derived: sum of 3 quarters · filed 2020-03-12 | -$56.28M 10-K · filed 2020-03-12 |
| 2018-09-30 | -$15.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$30.14M derived: sum of 2 quarters · filed 2019-11-07 | -$37.94M 10-Q · filed 2019-11-07 | -$47.04M derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | -$14.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | -$22.03M 10-Q · filed 2019-08-06 | -$31.13M derived: sum of 3 quarters · filed 2019-08-06 | -$36.70M derived: sum of 4 quarters · filed 2019-08-06 |
| 2018-03-31 | -$7.80M 10-Q · filed 2019-05-09 | -$16.91M derived: sum of 2 quarters · filed 2019-05-09 | -$22.48M derived: sum of 3 quarters · filed 2019-05-09 | |
| 2017-12-31 | -$9.10M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | -$14.68M derived: sum of 2 quarters · filed 2019-03-06 | -$24.66M 10-K · filed 2019-03-06 | |
| 2017-09-30 | -$5.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$15.56M 10-Q · filed 2018-11-08 | ||
| 2017-06-30 | -$9.99M 10-Q · filed 2018-08-14 |